BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29048741)

  • 1. Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.
    Niimi A; Igawa Y; Aizawa N; Honma T; Nomiya A; Akiyama Y; Kamei J; Fujimura T; Fukuhara H; Homma Y
    Neurourol Urodyn; 2018 Mar; 37(3):1113-1119. PubMed ID: 29048741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation.
    Maeda D; Akiyama Y; Morikawa T; Kunita A; Ota Y; Katoh H; Niimi A; Nomiya A; Ishikawa S; Goto A; Igawa Y; Fukayama M; Homma Y
    PLoS One; 2015; 10(11):e0143316. PubMed ID: 26587589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion.
    Choi D; Han JY; Shin JH; Ryu CM; Yu HY; Kim A; Lee S; Lim J; Shin DM; Choo MS
    Sci Rep; 2018 Jun; 8(1):9782. PubMed ID: 29955137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.
    Furuta A; Yamamoto T; Suzuki Y; Gotoh M; Egawa S; Yoshimura N
    Int Urogynecol J; 2018 Jul; 29(7):961-966. PubMed ID: 29372285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.
    Ke H; Zhu L; Wang Q; Xu K
    BMC Urol; 2023 Nov; 23(1):180. PubMed ID: 37940904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
    Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
    Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.
    Akiyama Y; Niimi A; Nomiya A; Yamada Y; Nakagawa T; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    Neurourol Urodyn; 2018 Apr; 37(4):1441-1447. PubMed ID: 29315774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Jiang YH; Jhang JF; Hsu YH; Kuo HC
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystectomy for patients with Hunner-type interstitial cystitis at a tertiary referral center in Japan.
    Akiyama Y; Niimi A; Igawa Y; Nomiya A; Yamada Y; Sato Y; Kawai T; Yamada D; Kume H; Homma Y
    Low Urin Tract Symptoms; 2022 Mar; 14(2):102-108. PubMed ID: 34704374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA (MEG3) in urinal exosomes functions as a biomarker for the diagnosis of Hunner-type interstitial cystitis (HIC).
    Liu F; Chen Y; Liu R; Chen B; Liu C; Xing J
    J Cell Biochem; 2020 Feb; 121(2):1227-1237. PubMed ID: 31595563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
    Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
    Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics.
    Lee YK; Jhang JF; Jiang YH; Hsu YH; Ho HC; Kuo HC
    Sci Rep; 2021 Aug; 11(1):17258. PubMed ID: 34446784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of diagnostic serum biomarkers for Hunner-type interstitial cystitis.
    Torimoto K; Ueda T; Kasahara M; Hirayama A; Matsushita C; Matsumoto Y; Gotoh D; Nakai Y; Miyake M; Aoki K; Fujimoto K
    Low Urin Tract Symptoms; 2022 Sep; 14(5):334-340. PubMed ID: 35307976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Defensin 2, an Antimicrobial Peptide, as a Novel Biomarker for Ulcerative Interstitial Cystitis; Can β-Defensin 2 Suspect the Dysbiosis of Urine Microbiota?
    Lee SW; Kim SH; Lee KW; Kim WB; Choi HW; Moon JE; Moon A; Kim YH
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of intravesical dimethyl sulfoxide treatment for patients with refractory Hunner-type interstitial cystitis: Real-world data postofficial approval in Japan.
    Akiyama Y; Niimi A; Nomiya A; Taguchi S; Yamada Y; Sato Y; Kawai T; Yamada D; Kume H; Homma Y
    Int J Urol; 2024 Feb; 31(2):111-118. PubMed ID: 37817647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The O'Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution.
    Yoshimura N; Uno T; Sasaki M; Ohinata A; Nawata S; Ueda T
    Int J Urol; 2022 Apr; 29(4):289-296. PubMed ID: 34929761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hunner Lesion Phenotype in Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis.
    Lai HH; Pickersgill NA; Vetter JM
    J Urol; 2020 Sep; 204(3):518-523. PubMed ID: 32223699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crowdsourcing Disease Biomarker Discovery Research: The IP4IC Study.
    Chancellor MB; Bartolone SN; Veerecke A; Lamb LE
    J Urol; 2018 May; 199(5):1344-1350. PubMed ID: 29225061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
    Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CXCR3 Expression of Infiltrating Plasma Cells in Hunner Type Interstitial Cystitis.
    Akiyama Y; Morikawa T; Maeda D; Shintani Y; Niimi A; Nomiya A; Nakayama A; Igawa Y; Fukayama M; Homma Y
    Sci Rep; 2016 Jun; 6():28652. PubMed ID: 27339056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.